Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-09-09 to 2024-09-10
Current total value of award: $589
Description: 4565918409!LORAZEPAM 2 MG/ML VIALML